October marks Breast Cancer Awareness Month, an important time to highlight advances in breast cancer diagnosis and treatment.
In the UK, Synnovis is pioneering a revolutionary approach to breast cancer care with the introduction of liquid biopsy technology, known as circulating tumour DNA (ctDNA) testing. This innovative technique allows healthcare professionals to monitor and detect tumour progression through a simple blood sample, potentially eliminating the need for invasive biopsies.
